Immediate Release
                                5 February 2010


                             ReGen Therapeutics Plc
                           ('ReGen' or the Company')
                              Total Voting Rights

For  the  purposes  of  the  Disclosure  and Transparency Rules of the Financial
Services  Authority, the Board of ReGen is  required to notify the market of the
following:

As at the date of this announcement, the Company's issued share capital consists
of  45,063,215 ordinary shares with a nominal  value of 0.01 p each, with voting
rights  ("Ordinary Shares").  The Company  does not  hold any Ordinary Shares in
Treasury.

Therefore  the total number of Ordinary Shares in the Company with voting rights
is 45,063,215.

The  above figure of  45,063,215 Ordinary Shares may  be used by shareholders in
the Company as the denominator for the calculations by which they will determine
if  they are required to notify their interest in, or a change to their interest
in,  the share  capital of  the Company  under the Financial Service Authority's
Disclosure and Transparency Rules.


ENDS

For further information:

Percy Lomax
ReGen Therapeutics Plc
Tel: 020 7153 4920

Roland Cornish/Felicity Geidt
Beaumont Cornish Limited
Tel: 020 7628 3396







[HUG#1381200]